Lexicon Pharmaceuticals | LXRX - 借入資本





借入資本 変化する 日付
Abbott USD 29.64B 19.74B 2026-03
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
AstraZeneca USD 25.96B 177M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Coherus Biosciences USD 51.08M 496K 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Illumina USD 1.49B 0 2026-03
Insmed USD 542.22M 1.25M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 37.53B 1.91B 2026-03
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
MannKind USD 548.07M 371K 2026-03
Merck USD 46.67B 77M 2026-03
Moderna USD 603M 7M 2026-03
Novartis USD 37.45B 7.86B 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12